Literature DB >> 17045083

Genetic basis of cancer of the kidney.

Sunil Sudarshan1, W Marston Linehan.   

Abstract

Kidney cancer is not a single disease. It is made up of a number of different types of cancer that occur in the kidney, each with a different histologic type, having a different clinical course, responding differently to therapy and caused by a different gene. The identification of families with a predisposition to the development of renal neoplasms, including von Hippel-Lindau (VHL), hereditary papillary renal carcinoma (HPRC), Birt-Hogg-Dubé (BHD), and hereditary leiomyomatosis and renal cell cancer (HLRCC), has made possible the identification of the different genes for these cancers. The genetic basis for each of these has been identified with current investigation focusing on the mechanisms of carcinogenesis. The elucidation of molecular pathogenesis in these familial forms of kidney cancer should provide the opportunity to determine successful approaches for novel therapeutic agents.

Entities:  

Mesh:

Year:  2006        PMID: 17045083     DOI: 10.1053/j.seminoncol.2006.06.008

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  14 in total

Review 1.  Management of locally recurrent kidney cancer.

Authors:  Eric A Singer; Gennady Bratslavsky
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

Review 2.  Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis.

Authors:  Markku Miettinen
Journal:  Mod Pathol       Date:  2014-01       Impact factor: 7.842

3.  Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients.

Authors:  Chiara Grisanzio; Apryle Seeley; Michelle Chang; Michael Collins; Arianna Di Napoli; Su-Chun Cheng; Andrew Percy; Rameen Beroukhim; Sabina Signoretti
Journal:  J Pathol       Date:  2011-06-27       Impact factor: 7.996

Review 4.  Epidemiology and risk factors for kidney cancer.

Authors:  Wong-Ho Chow; Linda M Dong; Susan S Devesa
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

Review 5.  Targeted therapies for non-clear renal cell carcinoma.

Authors:  Eric A Singer; Gennady Bratslavsky; W Marston Linehan; Ramaprasad Srinivasan
Journal:  Target Oncol       Date:  2010-08-03       Impact factor: 4.493

Review 6.  Landmarks in the diagnosis and treatment of renal cell carcinoma.

Authors:  Jaimin R Bhatt; Antonio Finelli
Journal:  Nat Rev Urol       Date:  2014-08-12       Impact factor: 14.432

7.  LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.

Authors:  Han Xie; Vladimir A Valera; Maria J Merino; Angela M Amato; Sabina Signoretti; William M Linehan; Vikas P Sukhatme; Pankaj Seth
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

8.  Feasibility and outcomes of repeat partial nephrectomy.

Authors:  Aaron Johnson; Sunil Sudarshan; Jack Liu; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

9.  Renal cell carcinoma and prognostic factors predictive of survival.

Authors:  M Sorbellini; G Bratslavsky
Journal:  Ann Surg Oncol       Date:  2010-02       Impact factor: 5.344

10.  Decreasing the indications for radical nephrectomy: a study of multifocal renal cell carcinoma.

Authors:  Maximiliano Sorbellini; Gennady Bratslavsky
Journal:  Front Oncol       Date:  2012-08-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.